Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACTION - The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension

NCT07013149 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.

NCT NCT07013149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07013149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACTION - The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension
Lead sponsor
University of Sao Paulo General Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 20, 2025
Completion date
December 1, 2026
Enrollment
183 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension, pulmonary arterial hypertension (pah), pulmonary arterial hypertension (pah) (who group 1 ph)